These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 3127207

  • 1. Binding of tissue-type plasminogen activator to fibrinogen fragments.
    Bosma PJ, Rijken DC, Nieuwenhuizen W.
    Eur J Biochem; 1988 Mar 01; 172(2):399-404. PubMed ID: 3127207
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Study of tissue-type plasminogen activator binding sites on fibrin using distinct fragments of fibrinogen.
    Grailhe P, Nieuwenhuizen W, Anglés-Cano E.
    Eur J Biochem; 1994 Feb 01; 219(3):961-7. PubMed ID: 8112348
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Fibrin-mediated plasminogen activation.
    Nieuwenhuizen W.
    Ann N Y Acad Sci; 2001 Feb 01; 936():237-46. PubMed ID: 11460481
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The sequence A alpha-(154-159) of fibrinogen is capable of accelerating the t-PA catalysed activation of plasminogen.
    Schielen WJ, Adams HP, Voskuilen M, Tesser GI, Nieuwenhuizen W.
    Blood Coagul Fibrinolysis; 1991 Jun 01; 2(3):465-70. PubMed ID: 1932532
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis.
    Weitz JI, Leslie B, Ginsberg J.
    J Clin Invest; 1991 Mar 01; 87(3):1082-90. PubMed ID: 1900308
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Fibronectin decreases the stimulatory effect of fibrin and fibrinogen fragment FCB-2 on plasmin formation by tissue plasminogen activator.
    Beckmann R, Geiger M, de Vries C, Pannekoek H, Binder BR.
    J Biol Chem; 1991 Feb 05; 266(4):2227-32. PubMed ID: 1824940
    [Abstract] [Full Text] [Related]

  • 13. [Binding of lys-plasminogen to E-fragment of fibrinogen].
    Kudinov SA, Andrianov SI, Lezhen TI.
    Biokhimiia; 1988 Oct 05; 53(10):1684-90. PubMed ID: 3233226
    [Abstract] [Full Text] [Related]

  • 14. Location of plasminogen-binding sites in human fibrin(ogen).
    Váradi A, Patthy L.
    Biochemistry; 1983 May 10; 22(10):2440-6. PubMed ID: 6222763
    [Abstract] [Full Text] [Related]

  • 15. Influence of various structural domains of fibrinogen and fibrin on the potentiation of plasminogen activation by recombinant tissue plasminogen activator.
    de Serrano VS, Urano T, Gaffney PJ, Castellino FJ.
    J Protein Chem; 1989 Feb 10; 8(1):61-77. PubMed ID: 2527513
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A monoclonal antibody preventing binding of tissue-type plasminogen activator to fibrin: useful to monitor fibrinogen breakdown during t-PA infusion.
    Holvoet P, Lijnen HR, Collen D.
    Blood; 1986 May 10; 67(5):1482-7. PubMed ID: 3083892
    [Abstract] [Full Text] [Related]

  • 19. Identification and characterization of novel lysine-independent apolipoprotein(a)-binding sites in fibrin(ogen) alphaC-domains.
    Tsurupa G, Ho-Tin-Noé B, Anglés-Cano E, Medved L.
    J Biol Chem; 2003 Sep 26; 278(39):37154-9. PubMed ID: 12853452
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.